• Company
• Samchundang to start oral insulin clinical trial this year
• by Kim, Jin-Gu Mar 26, 2021 05:37am

• Policy
• Lipilouzet, listed as the highest price for the same formula
• by Kim, Jung-Ju Mar 26, 2021 05:37am

• InterView
• “Amgen knows how to do it right in Korea”
• by Eo, Yun-Ho Mar 25, 2021 05:59am

• Policy
• Reduced drug price by expanding the scope of Abraxane
• by Kim, Jung-Ju Mar 25, 2021 05:58am

• Policy
• MOHW announces list of premium pricing benefit decision
• by Kim, Jung-Ju Mar 25, 2021 05:58am

• Company
• The patent dispute for the combination drug Ducarb expanded
• by Kim, Jin-Gu Mar 25, 2021 05:58am

• Opinion
• [Editor’s View] One year after the pandemic
• by Chon, Seung-Hyun Mar 25, 2021 05:58am

• Company
• ↑Sales of local subsidiaries in Japan & Southeast Asia
• by Kim, Jin-Gu Mar 24, 2021 07:28am

• Company
• Pneumococcal vaccine Prevenar 13 lowers COVID-19 risk
• by Eo, Yun-Ho Mar 24, 2021 05:46am

• Product
• Korean-made new drug Rolontis readies for FN drug market
• by Moon, sung-ho Mar 24, 2021 05:45am